Immunoelectron Microscopic Localization of Plasminogen Activator Inhibitor Type 1 (PAI-1) in Smooth Muscle Cells from Morphologically Normal and Atherosclerotic Human Arteries

References

• Ross R. Cell biology of atherosclerosis. Annu Rev Physiol. 1995; 57: 791–804
   PubMed Web of Science ®Google Scholar
• Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801–809
   PubMed Web of Science ®Google Scholar
• Stary HC, Blankenhorn DH, Chandler AB, et al. A definition of the intima of human arteries and of its atherosclerosis-prone regions: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Special report. Circulation 1992; 85: 391–405
   PubMed Web of Science ®Google Scholar
• Stary HC, Chandler AB, Glagov S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Special report. Arterioscler Thromb. 1994; 14: 840–856
   PubMed Web of Science ®Google Scholar
• Stary HC, Chandler AB, Dinsmore RE, et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association, Special report. Arterioscler Thromb Vase Biol. 1995; 15: 1512–1531
   PubMed Web of Science ®Google Scholar
• Libby P. Molecular basis of the acute coronary syndromes. Circulation 1995; 91: 2844–2850
   PubMed Web of Science ®Google Scholar
• Takaichi S, Yutani C, Fujita H, Yamamoto A. Ultrastructural studies on the phenotypic modulation of human intimal smooth muscle cells. Atherosclerosis 1993; 100: 197–211
   PubMedGoogle Scholar
• Campbell GR, Campbell JH. Smooth muscle phenotypic changes in arterial wall homeostasis: Implications for the pathogenesis of atherosclerosis. Exp Mol Pathol. 1985; 42: 139–162
   PubMed Web of Science ®Google Scholar
• Campbell GR, Campbell JH, Manderson JA, Horrigan S, Rennick RE. Arterial smooth muscle: a multifunctional mesenchymal cell. Arch Pathol Lab Med. 1988; 112: 977–986
   PubMed Web of Science ®Google Scholar
• He CS, Wilhelm SM, Pentland AP, et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989; 86: 2632–2637
   PubMed Web of Science ®Google Scholar
• Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES. Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vase Biol. 1995; 15: 1432–1443
   PubMed Web of Science ®Google Scholar
• Schneider DJ, Ricci MA, Taatjes DJ, et al. Changes in arterial expression of fibrinolytic system proteins in atherogenesis. Arterioscler Thromb Vase Biol. 1997, in press
   Google Scholar
• Padro T, Emeis JJ, Steins M, Schmid KW, Kienast J. Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presences and severity of atherosclerotic disease. Arterioscler Thromb Vase Biol. 1995; 15: 893–902
   PubMed Web of Science ®Google Scholar
• Schneidermann J, Sawdey SM, Keeton MR, et al. Increased type 1 plasminogen activator inhibitor-1 gene expression in atherosclerotic human arteries. Proc Natl Acad Sci USA 1992; 89: 6998–7002
   PubMedGoogle Scholar
• Lupu F, Bergonzelli GE, Heim DA, et al. Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries. Arterioscler Thromb. 1993; 13: 1090–1100
   PubMed Web of Science ®Google Scholar
• Chomiki N, Henry M, Alessi MC, Anfosso F, Juhan-Vague I. Plasminogen activator inhibitor-1 expression in human liver and healthy or atherosclerotic vessel walls. Thromb Haemostas. 1994; 72: 44–53
   PubMed Web of Science ®Google Scholar
• Liou W, Geuze HJ, Slot JW. Improving structural integrity of cryosections for immunogold labeling. Histochem Cell Biol. 1996; 106: 41–58
   PubMed Web of Science ®Google Scholar
• Tokuyasu KT. Use of poly(vinylpyrrolidone) and polyvinyl alcohol) for cryoultramicrotomy. Histochem J. 1989; 21: 163–171
   PubMedGoogle Scholar
• Schneider DJ, Absher PM, Ricci MA. The dependence of augmentation of arterial endothelial cell expression of plasminogen activator inhibitor type 1 by insulin on soluble factors released from vascular smooth muscle cells. Circulation 1997, in press
   Google Scholar
• Russo RN, Shaper NL, Taatjes DJ, Shaper JH. B1,4-galactosyltransferase: a short NH2-terminal fragment that includes the cytoplasmic and transmembrane domain is sufficient for Golgi retention. J Biol Chem. 1992; 267: 9241–9247
   PubMedGoogle Scholar
• Slot JW, Geuze HJ. A new method of preparing gold probes for multiple-labeling cytochemistry. Eur J Cell Biol. 1985; 38: 87–93
   PubMed Web of Science ®Google Scholar
• Roth J. The protein A-gold (pAg) technique: a qualitative and quantitative approach for antigen localization on thin sections. Techniques in Immunocytochemistry, GR Bullock, P Petrusz. Academic, London 1982; Vol 1: 108–133
   Google Scholar
• Nielsen LS, Andreasen PA, Grondahl-Hansen J, Huang J-Y, Kristensen P, Dano K. Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells: inhibitor neutralization and one-step affinity purification. Thromb Haemostas. 1986; 55: 206–212
   PubMedGoogle Scholar
• Ellis V, Dano K. The urokinase receptor and the regulation of cell surface plasminogen activation. Fibrinolysis 1992; 6(S4)27–32
   Google Scholar
• He CS, Wilhelm SM, Pentland AP, et al. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 1989; 86: 2632–2637
   PubMed Web of Science ®Google Scholar
• Chapman HA, Jr, Stone OL. Co-operation between plasmin and elastase degradation by intact murine macrophages. Biochem J. 1989; 222: 721–725
   Google Scholar
• Chapman HA, Jr, Reilly JJ, Jr, Kobzik L. Role of plasminogen activator in degradation of extracellular matrix protein by live human alveolar macrophages. Am Rev Respir Dis. 1988; 137: 412–419
   PubMedGoogle Scholar
• Clowes AW, Clowes MM, Au YP, Reidy MA, Belin D. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res. 1990; 67: 61–67
   PubMed Web of Science ®Google Scholar
• Sawa H, Sobel BE, Fujii S. Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury. Circ Res. 1993; 73: 671–680
   PubMedGoogle Scholar
• Sawa H, Lundgren C, Sobel BE, Fujii S. Increased intramural expression of plasminogen activator inhibitor type 1 after balloon injury: a potential progenitor of restenosis. J Am Coll Cardiol. 1994; 24: 1742–1748
   PubMed Web of Science ®Google Scholar